Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercus coccifera methanolic extract is a **plant-derived crude phytochemical extract** prepared from the leaves of *Quercus coccifera* and studied in academic preclinical research rather than commercial drug development. It is a complex mixture reported to contain polyphenols and other secondary metabolites, including gallic acid derivatives, gallotannins, flavonoid glycosides, alkaloids, terpenoids, and tannins. Its pharmacology appears to be **multicomponent and nonspecific**, with reported in vitro antioxidant activity and experimental inhibition of carbohydrate-digesting enzymes such as alpha-amylase and alpha-glucosidase, as well as cytotoxic activity against breast, lung, and prostate cancer cell lines. No approved pharmaceutical product, standardized active pharmaceutical ingredient, brand name, or clearly identified commercial developer/manufacturer was established from the provided context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quercus coccifera methanolic extract.